Victory Capital Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-7,466
| Closed | -$439K | – | 2615 |
|
|
2023
Q4 | $439K | Buy |
7,466
+400
| +6% | +$23.5K | ﹤0.01% | 2031 |
|
|
2023
Q3 | $308K | Buy |
7,066
+1,264
| +22% | +$55.1K | ﹤0.01% | 2113 |
|
|
2023
Q2 | $210K | Sell |
5,802
-134
| -2% | -$4.84K | ﹤0.01% | 2195 |
|
|
2023
Q1 | $221K | Buy |
5,936
+67
| +1% | +$2.49K | ﹤0.01% | 2226 |
|
|
2022
Q4 | $266K | Sell |
5,869
-4
| -0.1% | -$181 | ﹤0.01% | 2197 |
|
|
2022
Q3 | $410K | Buy |
+5,873
| New | +$410K | ﹤0.01% | 2142 |
|
|
2022
Q2 | – | Sell |
-108,150
| Closed | -$8.89M | – | 2767 |
|
|
2022
Q1 | $8.89M | Buy |
108,150
+17,910
| +20% | +$1.47M | 0.01% | 1153 |
|
|
2021
Q4 | $13.2M | Buy |
+90,240
| New | +$13.2M | 0.01% | 1048 |
|
|
2021
Q2 | – | Sell |
-93,330
| Closed | -$16M | – | 2824 |
|
|
2021
Q1 | $16M | Sell |
93,330
-296,812
| -76% | -$50.8M | 0.02% | 990 |
|
|
2020
Q4 | $85.7M | Buy |
390,142
+7,131
| +2% | +$1.57M | 0.1% | 313 |
|
|
2020
Q3 | $63.6M | Buy |
383,011
+19,551
| +5% | +$3.25M | 0.08% | 360 |
|
|
2020
Q2 | $41.5M | Sell |
363,460
-469,822
| -56% | -$53.6M | 0.06% | 492 |
|
|
2020
Q1 | $64.1M | Buy |
833,282
+409,230
| +97% | +$31.5M | 0.05% | 488 |
|
|
2019
Q4 | $54.6M | Buy |
424,052
+72,768
| +21% | +$9.38M | 0.07% | 435 |
|
|
2019
Q3 | $27.4M | Buy |
351,284
+81,494
| +30% | +$6.35M | 0.04% | 685 |
|
|
2019
Q2 | $27.8M | Buy |
+269,790
| New | +$27.8M | 0.06% | 498 |
|